About Agile
Founded in 1997, Agile Therapeutics has discovered and developed a pipeline of contraceptive products that represent significant near-term revenue potential. Formulated with active ingredients recognized for their efficacy and safety, these products will provide women with more convenient contraceptive options to potentially improve compliance. With two contraceptive patches in late-stage development and several additional contraceptive patch products ready to enter the clinic, the Agile Therapeutics pipeline is positioned to compete in the over $4 billion contraceptive market.
Agile has assembled an experienced management team who has worked with both large and small companies in women’s health and specialty pharmaceuticals. Agile also benefits from the support of some of the most respected long-term healthcare investors. The Company has completed several rounds of financing and in June 2010 announced the completion of Series B funding.
The Company headquarters are located in Princeton, NJ.